Published in

Elsevier, American Journal of Kidney Diseases, 4(54), p. 665-673, 2009

DOI: 10.1053/j.ajkd.2009.06.014

Elsevier, Year Book of Endocrinology, (2010), p. 286-287

DOI: 10.1016/s0084-3741(10)79572-x

Links

Tools

Export citation

Search in Google Scholar

Association of Kidney Function with Residual Hypertension after Treatment of Aldosterone-Producing Adenoma

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Background: Autonomous secretion of aldosterone in patients with primary aldosteronism increases glomerular filtration rate and causes kidney damage. The influence of a mild decrease in kidney function on residual hypertension after adrenalectomy is unexplored. Study Design: Nonconcurrent prospective study. Setting & Participants: The study was based on the Taiwan Primary Aldosteronism Investigation ( TAIPAI) database . 150 patients (61 men; overall mean age, 47 .2 +/- 11.6 years) with a diagnosis of aldosterone-producing adenoma had undergone unilateral adrenalectomy at National Taiwan University Hospital from July 1999 to January 2007. Predictor: Presurgery estimated glomerular filtration rate ( eGFR). Outcomes & Measurements: Residual hypertension after adrenalectomy , defined either as less than 75% of recorded blood pressure measurements with systolic blood pressure less than 140 mm Hg and diastolic blood pressure less than 90 mm Hg or requiring antihypertensive medications during the first year after surgery. Results: Before surgery, 27 ( 18%), 72 (48%), and 51 (34%) patients had moderately to severely decreased (= 90 mL/min/1.73 m(2)), respectively. After surgery , 16 (59. 3%), 29 (40.3%), and 10 (19.3%) patients in each category had postsurgery residual hypertension. Compared with patients without decreased eGFR before surgery, adjusted odds ratios for postsurgery residual hypertension were 2.7 ( 95% confidence interval, 1.03 to 7.0; P = 0.04) and 2.8 (95 % confidence interval, 1.05 to 9.3) for mildly and moderately to severely decreased eGFR, respectively. Limitations: Arbitrary definition for residual hypertension. Conclusions: Two-thirds of patients with aldosterone- producing adenoma were cured of hypertension by means of unilateral adrenalectomy. Kidney function impairment, even mild, appears to be associated with a high incidence of postsurgery residual hypertension. ; 附設醫院內科部 ; 醫學院附設醫院 ; 期刊論文